Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Patrick A. Flume, Reta Fischer Biner, D.G. Downey, Cynthia D. Brown, Manu Jain, Rainald Fischer, K. De Boeck, Gregory S. Sawicki, Philip M. Chang, Hildegarde Paz-Díaz, Jaime Rubin, Yoojung Yang, Xingdi Hu, David J. Pasta, Stefanie J. Millar, Daniel Campbell, Xin Wang, Neil Ahluwalia, Caroline A. Owen, Claire Wainwright, Ronald L. Gibson, Steven M. Rowe, Noah Lechtzin, Richard C. Ahrens, Karen McCoy, Moira L. Aitken, Scott H. Donaldson, Kimberly McBennett, Joseph M. Pilewski, Joanne Billings, Carlos Milla, Ronald C. Rubenstein, Daniel Rosenbluth, Rachel W. Linnemann, Michael R. Powers, Christopher N. Fortner, Carla A. Frederick, Theodore G. Liou, Philip Black, Janice Wang, John L. Colombo, Maria Berdella, M.V. Indihar, Cynthia D. Brown, Michael Anstead, Lara Bilodeau, Leonard Sicilian, Manu Jain, James Tolle, Kathryn Moffett, Samya Z. Nasr, Jennifer L. Taylor‐Cousar, Tara Lynn Barto, Nicholas Antos, John Rogers, Bryon Quick, Henry R. Thompson, Gregory S. Sawicki, Bruce Barnett, Robert Zanni, Thomas C. Smith, Karen D. Schultz, Claire Keating, Patrick A. Flume, Gregory J. Omlor, Alix Ashare, Karen Z. Voter, Nighat Mehdi, Maria Gabriela Tupayachi Ortiz, Tonia E. Gardner, Steven R. Boas, Barbara Messore, Edith T. Zemanick, Raksha Jain, Michael McCarthy, Dana G. Kissner, K. Patel, John McNamara, Julie V. Philley, Ariel Berlinski, Francisco J. Calimano, Terry Chin, Douglas Conrad, Cori Daines, Hengameh Raissy, Thomas G. Keens, Jorge Lascano, Bennie McWilliams, Brian Morrissey, Santiago Reyes, Subramanyam Chittivelu, Sabiha Hussain, Arvey Stone, James Wallace, Ross C. Klingsberg, Julie Biller, S. Bui, Olaf Sommerburg, Elisabetta Bignamini, Mirella Collura